title: Preparation and properties of arsonolipid containing liposomes.
abstract: Arsonolipids are analogs of phosphonolipids which have a chemically versatile head group. In preliminary cell culture studies, liposomes composed solely of arsonolipids or of phosholipid-arsonolipid mixtures, demonstrate a specific toxicity against cancer cells (Gortzi et al., unpublished results). The possibility of using such formulations as an alternative of arsenic trioxide with or without combination of other cytostatic agents (encapsulated in their aqueous interior) prompted the investigation of their physicochemical characteristics. Herein we compared the characteristics of arsonolipid containing vesicles with different lipid compositions. Experimental results and morphological observations reveal that non-sonicated formulations have different structures and stability (when both membrane integrity and aggregation are taken into account) depending on the acyl chain length of the arsonolipid. When phospholipids and especially cholesterol are included in their membranes almost all arsonolipids studied produce more stable vesicles. An interesting aspect of these arsonolipid containing vesicles is also their negative surface charge, which may be modulated by mixing phospholipids with arsonolipids. Sonicated vesicles have smaller sizes and profoundly higher stability, especially when containing cholesterol and phosphatidylcholine mixed with arsonolipids. The only exception is that of the arsonolipid with the C(12) acyl chain which was observed to produce long tubes which break down to cubes by sonication. In conclusion, these initial studies demonstrate that sonicated vesicles composed of arsonolipid and phospholipid mixtures mixed with cholesterol posses the stability required to be used as an arsonolipid delivery system. In addition, although cryo-electron microscopy demonstrated that the sonicated vesicles are elliptical in shape, their encapsulation efficiency is not significantly lower than sonicated phospholipid liposomes. Thereby, these vesicles may be also used for the delivery of other drug molecules which can be sufficiently retained in their aqueous interior.
authors.affiliation: Laboratory of Pharmaceutical Technology, Department of Pharmacy, University of Patras, Patras 26500, Greece.
authors.forename: D
authors.initials: D
authors.lastname: Fatouros
authors.forename: O
authors.initials: O
authors.lastname: Gortzi
authors.forename: P
authors.initials: P
authors.lastname: Klepetsanis
authors.forename: S G
authors.initials: SG
authors.lastname: Antimisiaris
authors.forename: M C
authors.initials: MC
authors.lastname: Stuart
authors.forename: A
authors.initials: A
authors.lastname: Brisson
authors.forename: P V
authors.initials: PV
authors.lastname: Ioannou
mesh_terms: D001152:Arsenicals / Q000737:chemistry*; D005453:Fluorescence; D008055:Lipids / Q000737:chemistry*; D008081:Liposomes; D008854:Microscopy, Electron / Q000379:methods; D013499:Surface Properties
chemical_list: D001152:Arsenicals; D008055:Lipids; D008081:Liposomes; C054806:arsonic acid